Related Experiment Video
Updated: Mar 15, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
29.8K
Improving Health Outcomes for Patients with Depression: A Population Health Imperative. Report on an Expert Panel
Janice L Clarke1, Alexis Skoufalos1, Alice Medalia2
11 Jefferson College of Population Health , Philadelphia, PA.
Population Health Management
|September 17, 2016
Summary
This report emphasizes improving health outcomes for depression as a population health imperative. Key recommendations focus on closing care gaps and enhancing patient experiences for better quality of life.
Area of Science:
- Population health
- Mental health outcomes
- Healthcare policy
Background:
- Depression significantly impacts population health, necessitating a strategic approach to improve patient outcomes.
- Addressing depression requires a multi-faceted strategy involving awareness, improved access to care, and employer engagement.
Discussion:
- Cognitive dysfunction in affective disorders presents a significant challenge requiring targeted interventions.
- Closing gaps in behavioral health professional availability and care processes is crucial for effective treatment.
- Shifting the focus of care discussions from cost to quality is essential for achieving the Triple Aim.
Key Insights:
- Employers play a critical role in supporting employees with depression and improving their health outcomes.
- Enhancing the patient experience of care is paramount for successful depression management.
- Improving the quality of care directly correlates with better health outcomes for individuals with depressive disorders.
Outlook:
- Continued focus on integrated care models and evidence-based practices will drive progress.
- Policy changes and employer initiatives are vital for sustainable improvements in depression care.
- Future efforts should prioritize patient-centered approaches to mental healthcare.
Related Concept Videos
01:18Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
01:28Acute Coronary Syndrome IV: Interprofessional Care
376
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
376
01:27Depressive Disorders: MDD and Dysthymia
1.0K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
01:25Antidepressant Drugs: Overview
1.9K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.9K
01:27Depressive Disorders: Etiology
827
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
827
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K